Joshua Pinto - 17 Apr 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Signature
/s/ Joshua Pinto
Issuer symbol
NMRA
Transactions as of
17 Apr 2024
Net transactions value
$0
Form type
4
Filing time
28 Jun 2024, 21:00:52 UTC
Previous filing
16 Feb 2024
Next filing
26 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Gift $0 -238,965 -50% $0.000000 238,965 17 Apr 2024 See footnote F1, F2
holding NMRA Common Stock 85,000 17 Apr 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 8, 2024, the Reporting Person transferred 238,965 shares of Common Stock to a family limited liability company (the "Family LLC") in a transaction exempt from reporting pursuant to Rule 16a-13. The transaction reported herein reflects the transfer for no consideration of membership interests in the Family LLC to a trust of which the Reporting Person is a beneficiary for estate planning purposes. The Reporting Person continues to exercise investment control over the Common Stock held by the Family LLC.
F2 Shares held by Maple DE Holdings LLC, which is the entity defined above as "Family LLC".